ViewRay Inc (VRAYQ)
ViewRay Inc is a common stock listing on OTC Markets in the healthcare sector. The company developed and commercialized magnetic resonance imaging-guided radiation therapy systems in the United States and internationally, including the MRIdian A3i platform. That system is designed to support real-time 3D tissue tracking and automated beam control for use in cancer treatment, including pancreas, prostate, lung, liver, breast, and oligometastatic cancers. Founded in 2004 and based in Oakwood, Ohio, ViewRay also disclosed significant financial distress: on July 16, 2023, the company and an affiliate filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the District of Delaware, and on October 26, 2023, ViewRay’s Chapter 11 case was converted to Chapter 7.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-VRAY.Q
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 5, 2026
|
—
|
—
|
—
|
0.183 K
|
—
|
—
|
—
|
—
|
—
|
—
|